To ensure this is delivered, rapid talks between the ABPI and the UK government to design and agree a new, more sustainable scheme model from 2029 onwards will begin in the New Year...Richard Torbett, Chief Executive of the ABPI, said.
In 2022, the ABPIClinical Trials Report2 signalled that the UK had reached a tipping point as a destination of choice for industry clinical trials ... The ABPI annual clinical trials report is an ...
Critically, the deal calls for rapid talks between the ABPI and the UK government to design and agree a new, more sustainable scheme model from 2029 onwards. Richard Torbett, Chief Executive of the ABPI, said.